A cheaper, safer CBD alternative? Scientists discover new synthetic CBD analogue alleviates seizures in rats

Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

19 Jun 2019 --- Set to be launched in September, the International Cannabinoid Analysis Program (ICAP) is a new third-party certification program for manufacturers and brands in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Jun 2019 --- US-based hemp ingredients company Victory Hemp Foods has launched two new functional and proprietary ingredients – Victory ONE Hemp Heart Oil and V-70 Hemp... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Jun 2019 --- Cannabinoid (CBD) manufacturer Noramco and Willow Biosciences, a developer of biosynthetic production systems for plant-derived active pharmaceutical ingredients... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 May 2019 --- Consumer interest in cannabidiol (CBD) is booming, with CBD-infused products proliferating at an astounding pace. Whether the cannabis extract has indeed proven its... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 May 2019 --- Regulatory confusion over cannabinoids (CBD) has opened up the space for alternatives, within which Gencor has released Levagen, a palmitoylethanolamide (PEA)... Read More